SFX by Ex Libris Inc.

Title:	Deregulation of DUX4 and ERG in acute lymphoblastic leukemia
Source:	Nature Genetics [1061-4036] Zhang, Jinghui yr:2016

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Bu, J. "SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia." Leukemia 32.4 (2017): 890-899.
description	2.	Lim, W. "Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts." Leukemia & lymphoma 51.8 (2010): 1536-1542.
description	3.	Comeaux, Evan Q. "TP53 Mutations in Hypodiploid Acute Lymphoblastic Leukemia." Cold Spring Harbor perspectives in medicine 7.3 (2016).
description	4.	Faber, Zachary J. "The genomic landscape of core-binding factor acute myeloid leukemias." Nature Genetics 48.12 (2016): 1551-1556.
description	5.	Benoit, E. "An intragenic ERG deletion (ERGdel) is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions." Leukemia 28.1 (2013): 70-77.
description	6.	Holmfeldt, L. "The genomic landscape of hypodiploid acute lymphoblastic leukemia." Nature Genetics 45.3 (2013): 242-52.
description	7.	"Incidence and Therapeutic Implications of Germline TP53 Mutations in Hypodiploid Childhood Acute Lymphoblastic Leukemia: A Retrospective Analysis of the Italian Cohort." Blood. 136.Supplement 1: 43-44.
description	8.	Lien, H. "Increased Trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma." PLoS ONE 13.10 (2018).
description	9.	Revista română de medicină de laborator. 23.2: 221-230.
description	10.	"Incidence and prognosis of RTKs and RAS mutations in CBF AML. A retrospective study of French adult ALFA and pediatric LAME trials." Blood : journal of the American Society of Hematology.
description	11.	Churchman, Michelle L. "Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia." Experimental hematology 46 (2017): 1-8.
description	12.	Harrison, J A E J. "The role of the RAS pathway in iAMP21-ALL." Leukemia 30.9 (2016): 1824-1831.
description	13.	Olsson, L. "The genetic landscape of paediatricde novoacute myeloid leukaemia as defined by single nucleotide polymorphism array and exon sequencing of 100 candidate genes." British journal of haematology 174.2 (2016): 292-301.
description	14.	Hirsch, B. "Integration of cytogenomic data for furthering the characterization of pediatric B-ALL: a multi-institution, multi-platform microarray study." Cancer Genetics 208.1-2 (2014): 1-18.
description	15.	Stanulla, M. "ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia." Leukemia 28.1 (2014): 182-185.
description	16.	Chiaretti, S. "TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy." Haematologica 98.5 (2013): -61.
description	17.	Krauth, M-T T. "High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome." Leukemia 28.7 (2014): 1449-1458.
description	18.	Den Boer, Monique L L. "A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome : a genome-wide classification study." The lancet oncology 10.2 (2009): 125-134.
description	19.	Kandoth, C. "Mutational landscape and significance across 12 major cancer types." Nature 502.7471 (2013): 333-339.
description	20.	Thomas, D. "Protein Kinase Activity of Phosphoinositide 3-Kinase Regulates Cytokine-Dependent Cell Survival." PLoS Biology 11.3 (2013).